Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Cost of Revenue (2016 - 2023)

Historic Cost of Revenue for Mesoblast (MESO) over the last 9 years, with Q2 2023 value amounting to -$334.2 million.

  • Mesoblast's Cost of Revenue fell 1013.64% to -$334.2 million in Q2 2023 from the same period last year, while for Jun 2023 it was $129.1 million, marking a year-over-year increase of 2092.93%. This contributed to the annual value of $5.1 million for FY2025, which is N/A changed from last year.
  • Mesoblast's Cost of Revenue amounted to -$334.2 million in Q2 2023, which was down 1013.64% from $123.4 million recorded in Q1 2023.
  • Mesoblast's 5-year Cost of Revenue high stood at $252.3 million for Q3 2022, and its period low was -$339.7 million during Q2 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $69.0 million (2019), whereas its average is $2.2 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first crashed by 823120.92% in 2020, then soared by 274837.21% in 2021.
  • Quarter analysis of 5 years shows Mesoblast's Cost of Revenue stood at $86.3 million in 2019, then crashed by 92.53% to $6.4 million in 2020, then skyrocketed by 2748.37% to $183.7 million in 2021, then tumbled by 52.31% to $87.6 million in 2022, then tumbled by 481.46% to -$334.2 million in 2023.
  • Its last three reported values are -$334.2 million in Q2 2023, $123.4 million for Q1 2023, and $87.6 million during Q4 2022.